9999999997-18-008376.txt : 20181004
9999999997-18-008376.hdr.sgml : 20181004
20181004105403
ACCESSION NUMBER: 9999999997-18-008376
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20181004
DATE AS OF CHANGE: 20181004
ACTION DATE: 20181004
RECEIVED DATE: 20181004
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Altimmune, Inc.
CENTRAL INDEX KEY: 0001326190
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202726770
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-226441
FILM NUMBER: 181107216
BUSINESS ADDRESS:
STREET 1: 910 CLOPPER ROAD
STREET 2: SUITE 201S
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 2406541450
MAIL ADDRESS:
STREET 1: 910 CLOPPER ROAD
STREET 2: SUITE 201S
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMATHENE, INC
DATE OF NAME CHANGE: 20071016
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP
DATE OF NAME CHANGE: 20050505
CT ORDER
1
filename1.pdf
begin 644 filename1
M)5!$1BTQ+C4-)>+CS],-"C$P(# @;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S
M=')E86T-96YD;V)J#7-T87)T>')E9@T*, T*)25%3T8-"B @(" @(" @#0HR
M,B P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X-"],(#8X+TQE;F=T
M:" V,2]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G (.#094P C$+ P<#7!E+T-A=&%L;V<^/@UE;F1O8FH-,3(@
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MH\OTX653;U)M5F1Y,R.9/IKU>&SEWY;P4Q6MMHMP.JV/JU$8
MQC 25-KYJ!V<\FCMHC-5YL7SARPO=0L+_0ONZU)5'UULH4I-7,0&G'^9CJ9U
ML9UG+IZ:1IO-GBSJIE2%6#_<^1GP^UV'*3
M'TS=D.^#4=R@4]5JU+Q6_K;:U-N\VI''O)I4;=Z_S_*F-==[U8#@%U7PHO&2
MOJI.P9@DZ=,/@PUES9-VG?7MV4]OS;Y=\9 "6DC]/C2,"2' :U!QN?[D&9KD
MO'OBBB()$6.6P-@M$2=.A?XD"+Q.QGUF&$8NYK]"^_UDIWJH"VP^[9ZN]^X[
MN,=V!M2<]%XEO'?]7O2BE^A1^3;T_DI=\ IU,7\?=&_EC=,+WCC[#][.AO>
MZ]^(>TG>^9Z'Q#G..FZ0-[S[OE+'W-E0Z167?)T-B<%ZP]WQTW4SI T)ONSV
M5)D/8HYP?[8,_A9@ -M(A1P-"F5N9'-T
MK%9;;^(X%'[G5QQI7YP5\>1*DGFC7#J,ME2"5%IINEJ%Q(!7(6%RF4[__1Y?
MD@9*9U\6)+ =^UR^[SO'^72_M>%0C^[BT:#^R';#PBW^1!8$5TM"#
M^#2RX# RJ85;4AS'+R,"8,3_X-BTJ>U#/!?+*2Z+5=L36_LG>-"R(_%8#UY&
MW\C3>A4O#-.C$9G#UC!]&I#8H#:9QFIUH1?!^"O^.C(G- C\2YO61-L4 V%S
MNY@];5;QRL#='AJ Z7H.Z,2E$_+G[,MT?:\G,'M\>%AMMZO'M3(?4#=Z,RY,
M^L*V\.+*=!_3IMRQ"KPQ.)8=RC1-S'/B^%<0:'C$!I]&DZN0.Q@L#C3OJ-.K^8+/#'] ^+-8AH_X$2C
M%=&)=S.NI[7P%W]90 >6@&D6P^,2[,AU56(A#0:!]Z3Z]B5&3H>1)>,AT[SA
MIU-;L#&LBI3*8R[UHH\1$K0.'I,ESQFL2PJNZYJ.,_$\= FSY6_N)$ ERCBH
M/TB-_'WK(S>BJ#TE:A-QU.+QWA*R;A".^[S(5^""2L<(J4MD3H83>#Y1F3F!
M;Y&ZW:G'O&E8IAASI4ZM=Q )SR+KI(#D?,YYFC2\+* M,E35ILV9S,VB_N!P
MKT''UB%Y*/6*?6]9W?#B &E9[UR=YP\9=GK&AXDFL-.!YUA^KLY6<.]-=4
M+&E$$@'!P[ O*^ %_JHE%2-O@/U,\S9C&>RK\J02#:CEW C5UM*$Q<\CW^%1
MS"F$IH0$ELJL2V!KVIC&@==-I5RHB)7-BX#=/F!7V:V;I&'"C*T"1L%D@!:^
MMODKN)8JSS$D-23=+HR;*@_Q[^\4B$O"NMW[Z: V3,GQ75(K!Q4[5ZQ&GS+B
M&G:O<*%WZ<"QJ!L.& Q[6$)E%K73')&SD"0&=@_2&)BN1W"1UP)Y)#(DI8$_
MU4E!\[U5.W.N'G)6B^PTQ\K?!61>KQK-,:IDWVLC+4\G5J5BB%SO>9$4S;&TN&<_^"U,(G.9F5U+E%0LI("&KH#
M(B8]*%J?XLQ29L_@B'AFK&%2GA[A!3)>E(U0[;G=8:VBM/IHA=G+?B9#E5<0
MR7B=YF7-L&8H8)II6658J/GK&'1].\/N\):IIJJOLYZ.@"@9*^!D^8FI3+Z_
M(P8,70F9[,L\+U]$LV"Z(%]XGLOT=DSU8 >[WN3Z;@U40!7+F:P Q$*X5'C(
M/B&FJ'\#"21,R!BC.K.*EQG49Y;R/6?9Y_^J.[?ONMHA0-\Y5).5_<.P(VR]
MZ+(JV\-1/]FR<]<*Q-6L%AUKW(\"U&.19.X4JGB+*21?:MY!BJL3LD#D8X1^JINDT+*4KU^
M2"N_BI!D2-\!&V8&2=L!GR]**-4GUB@UV0GXEO?]W8 \NK0XP'9+6UR(>_2O $?$SG8-"F5N
M9'-T
M,E,P4#!7,+10L+'1]RO-+8X&<0T4@F+M[( BP?HN=G8 08 C84(-PT*96YD
MFMC.60B/SX*/'@Z>&UP;65T
M82!X;6QN#IX;7!T:STB061O8F4@6$U0
M($-O"UN&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D
M9B\Q+C,O(@H@(" @(" @(" @("!X;6QN&UL.FQA;F<](G@M9&5F875L="(^36EC&UP.D-R96%T941A=&4^,C Q."TQ,"TP
M-%0Q,#HU,CHR,"TP-#HP,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX
M;7 Z0W)E871O&UP34TZ26YS=&%N8V5)1#YU
M=6ED.F,P.&4Y8S0S+39D9&4M-#)E-2UB-3&UP
M34TZ26YS=&%N8V5)1#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO
MJ'5!:DZ@?,RQ"L(P$(#A5[G-=+"]
MIA:JE()8%T$0%+NXQ"9J,/3DI-^)4O])8-B7BHL1::YSC8H8X^ZF4'8XC^Y?4N0T!SHYC*J'.=:ZS8D_V
M_^3 9-^C8[4>F:Y&H/=1? B.H6QRA(L:_&3I$R]95IR\!*?V/M%(-X&!V,(<
M[FPFF=RGJA*O$NRZKP # "I=02 -"F5N9'-TF4@,3 O5'EP
M92]84F5F+U=;,2 R(#%=/CYS=')E86T-"FC>8F( B9&KA,,3 R,;4""=R&(
MU0LB.($2SVJ + 8&1B#!]!](,#( !!@ ?+L%&PT*96YD